ConductScience.org, home

Paper6290

Studies on the centrally mediated hypotensive activity of guanabenz.

Baum T and 1 other. Eur J Pharmacol, 1976. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Studies on the centrally mediated hypotensive activity of guanabenz. Papers, record 6290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies on the centrally mediated hypotensive activity of guanabenz.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.05
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baum TT
2Shropshire ATA T

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PressureMajor topic
GuanabenzMajor topic
GuanidinesMajor topic
Adrenergic alpha-Antagonists
Animals
Carotid Sinus
Cats
Denervation
Depression, Chemical
Electric Stimulation
Female
Ganglia, Spinal
Hypothalamus
Male
Pressoreceptors

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
41619089The discovery of monoamine oxidase inhibitors: virtual screening and in vitro inhibition potencies.J Comput Aided Mol Des2026https://conductscience.org/library/papers/41619089PubMed
35820743Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study.BMJ Open2022https://conductscience.org/library/papers/35820743PubMed
33410111Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling.Neurotherapeutics2021https://conductscience.org/library/papers/33410111PubMed
33168944Guanabenz modulates microglia and macrophages during demyelination.Sci Rep2020https://conductscience.org/library/papers/33168944PubMed
26873788Harnessing the integrated stress response for the treatment of multiple sclerosis.Lancet Neurol2016https://conductscience.org/library/papers/26873788PubMed
26696956Remyelination Therapy in Multiple Sclerosis.Front Neurol2015https://conductscience.org/library/papers/26696956PubMed
26303803Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26303803PubMed
25766071Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.Nat Commun2015https://conductscience.org/library/papers/25766071PubMed
8564219Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.Br J Pharmacol1995https://conductscience.org/library/papers/8564219PubMed
6352237Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.Drugs1983https://conductscience.org/library/papers/6352237PubMed
6135165The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with alpha 2-adrenoceptor agonistic properties.Naunyn Schmiedebergs Arch Pharmacol1983https://conductscience.org/library/papers/6135165PubMed
3736681Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/3736681PubMed
26908A basis for migraine therapy- the autonomic theory reappraised.Postgrad Med J1978https://conductscience.org/library/papers/26908PubMed
22821Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type".Naunyn Schmiedebergs Arch Pharmacol1977https://conductscience.org/library/papers/22821PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6290

GET https://conductscience.org/api/papers/v1/6290/authors